My wife had tumour surgery, completed her first radiation therapy, and is now taking Nublast 250mg tablets. What is her prognosis with this treatment, and is the doctor's estimate of a 1 to 2-year life expectancy accurate?
Nublast (Temozolomide) is a chemotherapy drug used for aggressive brain tumors like Glioblastoma. Combined with surgery and radiation, it helps delay tumor progression. Regrettably, the doctor's estimate of a 1 to 2-year life expectancy is statistically accurate and reflects the standard median survival rate for this diagnosis. However, individual prognosis varies. Factors like her overall health, age, and specific tumor genetics (such as MGMT promoter methylation) can influence how well she responds to Nublast. Some patients exceed these averages. I encourage you to discuss these specific markers with her oncologist to better understand her personal outlook and focus on maximizing her quality of life.
Ask Apollo
AI powered Health Chatbot
My wife had tumour surgery, completed her first radiation therapy, and is now taking Nublast 250mg tablets. What is her prognosis with this treatment, and is the doctor's estimate of a 1 to 2-year life expectancy accurate?